Physician profile
Roy D Edwards
NPI 1255530309
$2,877.14
in general payments reported to CMS, 2019-2025
10 companies · $749 in 2025
The $749 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2021: $27.38 · 2022: $474 · 2023: $638 · 2024: $469 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,559 · Education: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,559.47 |
| Education | $297.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $824.14 | 2019-2025 | |
| Kerecis Limited | $714.61 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Avita Medical Americas, LLC | $479.03 | 2024-2025 | Recell, Permeaderm, Cohealyx |
| Progenacare Global, LLC | $323.51 | 2023 | |
| Teleflex LLC | $176.66 | 2024-2025 | Arrow, Quikclot |
| Depuy Synthes Sales INC. | $137.43 | 2022-2025 | Matrixrib |
| Polynovo North America LLC | $120.55 | 2024 | Novosorb Btm |
| Davol INC. | $61.42 | 2021-2023 | Arista Ah Flexitip |
| Covidien LP | $20.26 | 2019 | |
| Haemonetics Corporation | $19.53 | 2024 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.